Hittite Microwave Corporation Acquisition by Analog

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Hittite Microwave Corporation Acquisition by Analog Devices, Inc. May Not be in the Best Interests of Hittite Shareholders

NEW YORK, June 11, 2014 (GLOBE NEWSWIRE) -- The fairness of the proposed acquisition of Hittite Microwave Corporation ("HITT" or the "Company") by Analog Devices, Inc. ("ADI") is the subject of an examination by WeissLaw LLP, a national class action, shareholder rights law firm. The examination is focusing on possible breaches of fiduciary duty and other violations of law by the Board of Directors of HITT for agreeing to sell the Company to ADI. On Monday June 9, 2014, HITT and ADI jointly announced that they had entered into a definitive agreement for ADI to acquire all outstanding shares of HITT in a transaction valued at approximately $2 billion. Under the terms of the agreement, Company shareholders will receive $78 in cash for each HITT share they own.

WeissLaw LLP is investigating whether HITT's Board acted to maximize shareholder value prior to entering into the agreement with ADI. Notably, HITT recently reported positive financial results. On April 24, 2014, the Company reported revenue of $70.6 million for the first quarter 2014, an increase over both the previous quarter and the first quarter 2013. Moreover, the Company beat analysts' estimates for comparable adjusted net income in three of the last four quarters and estimates for comparable sales in every quarter during the past year.

Given these facts, WeissLaw is investigating the Board of Directors' decision to sell HITT and whether HITT shareholders will obtain their fair proportionate share of the Company's continued success and future growth prospects. If you own HITT shares and would like more information about your rights or our investigation, please contact Joshua Rubin or Kelly Keenan either by telephone at (888) 593-4771 or by email at stockinfo@weisslawllp.com.

The firm is also in the process of investigations on behalf of shareholders of American Realty Capital Healthcare Trust, Inc., Deutsche Telekom AG, Idenix Pharmaceuticals, and Protective Life Corporation.

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at stockinfo@weisslawllp.com or fill out the form on our website, http://www.weisslawllp.com/contact/report_fraud/ .

Attorney Advertising. Past results do not guarantee a similar outcome.

WeissLaw LLP Joshua Rubin Kelly Keenan 1500 Broadway, 16th Floor New York, NY 10036 T: 212.682.3025 F: 212.682.3010 www.weisslawllp.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 34

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 38

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 51

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 29

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 39

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 21

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 26

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering States to Value Workforce Credentials Effectively

Updated Category News Views 207

Initiating FutureReady States for Workforce Empowerment The FutureReady States initiative, spearheaded by the Lumina Foundation, is a transformative approach to evaluating workforce credential effectiveness. This program is designed to help states understand and enhance their investment in workforce training policies that yield significant economic benefits for both...

Continue Reading
Revolutionizing ADC Characterization with Biozen Native Columns

Updated Category News Views 467

Transforming Biotherapeutic Characterization First of its Kind in Biotherapeutic Antibody Characterization Phenomenex Inc., a leader in separation science technology, has launched Biozen Native RP-1 and RP-5 chromatography columns. These innovative products are engineered to meet the growing demand for effective characterization methods for Antibody-Drug Conjugates...

Continue Reading
Liberty HealthShare: A Compassionate Approach to Healthcare

Updated Category News Views 150

Liberty HealthShare: A Shift in Healthcare Sharing In recent years, many individuals have faced significant concerns about healthcare costs and insurance availability. Liberty HealthShare is stepping up to provide a compassionate alternative for those seeking an effective solution to diminishing healthcare options, especially amid rising premiums and decreasing coverage....

Continue Reading
SelectQuote, Inc. Announces Impressive Q2 Fiscal Results

Updated Category News Views 114

Record Quarter for SelectQuote, Inc. SelectQuote, Inc. (NYSE: SLQT) reported significant growth in its consolidated revenue for the second quarter of fiscal year 2025, reaching $481.1 million. This reflects a notable increase from $405.4 million in the same quarter of the prior year. Alongside revenue growth, the company achieved consolidated net income of $53.2 million,...

Continue Reading
Parker Hannifin to Reveal Fiscal 2025 Q2 Earnings Insights

Updated Category News Views 203

Parker Hannifin Corporation Upcoming Earnings Announcement Parker Hannifin Corporation (NYSE: PH), recognized as a global leader in motion and control technologies, has announced its plans to release its fiscal 2025 second quarter earnings. This exciting update is set to take place before the stock market opens on January 30, 2025. Investors and analysts eagerly...

Continue Reading